Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
General Medicine
Reference54 articles.
1. Shots of hope
2. Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19
3. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial
4. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
5. Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Update on the Clinical Applications of Mesenchymal Stem Cells;Journal of Stem Cell Therapy and Transplantation;2023-12-21
2. Mesenchymal stem cell therapy for COVID-19 infection;Inflammopharmacology;2023-12-20
3. Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 Infection;Journal of Stem Cell Therapy and Transplantation;2023-12-05
4. Hope on the horizon: Wharton's jelly mesenchymal stem cells in the fight against COVID-19;Regenerative Medicine;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3